Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection

Thrombosis Research

Volumn 81, Issue 2, 1996, Pages 213-218

  Pirich, Christian ^a   Efthimiou, Yamis ^b   O'Grady, John ^b   Zielinski, Christoph ^b   Sinzinger, Helmut ^b  

^a Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^b NONE

Author keywords

Apolipoprotein A; Biological half life; HDL cholesterol; HIV 1 infection; Neuropathy; Prostaglandin I2

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; PROSTACYCLIN; APOLIPOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; VIROLOGY; BLOOD LEVEL; CLINICAL ARTICLE; NEUROPATHY; PRIORITY JOURNAL;

ADULT; AIDS DEMENTIA COMPLEX; APOLIPOPROTEIN A-I; CHOLESTEROL; CROSS-SECTIONAL STUDIES; EPOPROSTENOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0029670274     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00238-3     Document Type: Article

References (23)

1. GERVAIS A, AYRAULT-JARRIER M, REBOUL J, SCHULLER E, MEILLET D, APARTIS E, LYON-CAEN O, BRICAIRE F, GENTILINI M. Apolipoprotein All in HIV-1 infection. Lancet, ii, 730-73, 1992
2. 2 stabilisation in septic shock patients. In: Sinzinger H, Schrör K: Prostaglandins in the Cardiovascular System, pp 204-209 Birkhäuser, Basel (1992).
3. 2 half-life in plasma. Wien Klin Wochenschr, 104, 705-706, 1992.
4. BAILLE EE, ORR CW. Lowered high-density lipoprotein cholesterol in viral illness. Clin Chem, 25, 817-818, 1979.
5. FRIEDLAND ML, HERBERT PN. Lipoprotein abnomalities associated with a viral syndrome. J Am Med Assoc, 248, 82, 1982.
6. GRUNFELD C, KOTLER DP, HAMADEH R, TIERNEY A, WANG J, PIERSON RN. Hypertriglyceridemia in the immunodeficiency syndrome. Am J Med, 86, 27-31, 1989.
7. GRUNFELD C, PANG M, DOERRLER W, SHIGENAGA JK, JENSEN P, FEINGOLD KR. Lipids, lipoproteins, triglyceride clearence, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab, 74, 1045-1052, 1992.
8. YUI YT, AOYAMA T, MORISHITA H, TAKAHASHI M, TAKATSU Y, KAWAI C. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (apo A-I). J Clin Invest 82, 803-807, 1988.
9. th Int Congr on Prostagl and Related Compounds Abstract 356, (Montreal 1992)
10. HAVEL RJ, EDER HA, BRAGDON JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34, 1345-1353, 1955.
11. MARCOVINA SM, ALBERS JJ. International Federation of Clinical Chemistry study on the standardisation of apolipoproteins A-I and B. Curr Opin Lipid, 2, 355-361,1991.
12. CAPRON L, KIM YU, LAURIAN C, BRUNEVAL P, FIESSINGER JN. Atheroembolism in HIV-positive individuals. Lancet, ii, 1039-1040, 1992.
13. TABIB A, GREENLAND T, MERCIER I, LOIRE R, MORNEX JF. Coronary lesions in young HIV-positive subjects at necropsy. Lancet, ii, 730, 1992.
14. HAJJAR DP. Viral pathogenesis of atherosclerosis, impact of molecular mimiery and viral genes Am J Pathol, 197, 1195-1211,1991
15. CHEN YC, MCLEOD B, HALL ER, WU KK. Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura Lancet, ii; 267-269, 1981.
16. WU KK, HALL ER, PAP AC. Prostacylin stabilising factor deficiency in thrombotic thrombocytopenic purpura. Lancet, i, 460-461, 1982.
17. 2 half-life regulated by high density lipoprotein is decreased in acute myocaridal infarction and unstable angina pectoris. Circulation, 81, 1784-1791, 1990
18. HUBER C, HAUSEN A, REIBNEGGER G. Immune response associated production of neopterin release from macrophages primarily under control of interferon gamma. J Exp Med, 160, 310-316,1984.
19. LEUNG KH, MICHICH F. Prostaglandin modulation of developement of cell mediated immunity in culture. Nature, 288, 597-599, 1980.
20. ROY P, SAFAI B. Increased plasma prostacyclin in AIDS J Acquir Immun Def Syndr, 4, 205-206, 1991
21. BREVIARIO F, PROSPERIO P, BERTOCCHI F, LAMPUGNANI MG, MANTOVANI A, DEJANA E. Interleukin-1 stimulates prostacyclin production by cultured human endothelial cells by increasing arachidonic acid mobilization and conversion. Arteriosclerosis, 10, 129-134, 1990.
22. ZANGERLE R, SARCLETTI M, GALLATI H, REIBNEGGER G, WACHTER H, FUCHS D. Decreased Plasma Concentrations of HDL Cholesterol in HIV-infected individuals are associated with immune activation. J Acquir Immun Def Syndr, 7, 1149-1156, 1994.
23. KALIMAN J, KOSTNER G, KRAUPP O, KUNZE M, SINZINGER H, WIDHALM K Richtlinien zur Prävention der Atherosklerose. Wien Klin Wochenschr; 99, 589-590, 1987.